Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator
- 1 September 1987
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 10 (3) , 479-490
- https://doi.org/10.1016/s0735-1097(87)80188-2
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Plasmin inhibition of platelet function and of arachidonic acid metabolism.Journal of Clinical Investigation, 1985
- Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.Journal of Clinical Investigation, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Effect of interventions in salvaging left ventricular function in acute myocardial infarction: A study of intracoronary streptokinaseThe American Journal of Cardiology, 1983
- Experimental validation of quantitative coronary arteriography for determining pressure-flow characteristics of coronary stenosis.Circulation, 1982
- Quantitative coronary angiography: measurement of the "critical" stenosis in patients with unstable angina and single-vessel disease without collaterals.Circulation, 1979
- Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation.Circulation, 1977